- Market Capitalization, $K 112,182
- Shares Outstanding, K 16,049
- Annual Sales, $ 38,780 K
- Annual Income, $ -1,570 K
- 60-Month Beta 0.59
- Price/Sales 2.91
- Price/Cash Flow 7.33
- Price/Book 0.67
|Period||Period Low||Period High||Performance|
| || |
+0.06 (+0.86%)since 06/14/19
| || |
-0.21 (-2.91%)since 04/16/19
| || |
-1.17 (-14.32%)since 07/16/18
NEW YORK (AP) _ Garrison Capital Inc. (GARS) on Tuesday reported first-quarter net income of $2.4 million.
Garrison Capital Inc., a business development company (Nasdaq: GARS), today announced its financial results for the first quarter ended March 31, 2019. Net investment income for the first quarter was $2.4...
Rise in total investment income and stable expenses support Ares Capital's (ARCC) Q1 earnings.
Garrison Capital (GARS) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Here are 5 stocks added to the Zacks Rank #5 (Strong Sell) List today.
In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of Aclaris Therapeutics, Inc....
Here are 5 stocks added to the Zacks Rank #5 (Strong Sell) List today:
Driven by strong fundamentals and good growth prospects, Credit Acceptance (CACC) seems to be a solid bet now.
Garrison Capital Inc., a business development company (Nasdaq: GARS), today announced its financial results for the fourth quarter and fiscal year ended December 31, 2018. Net investment income for the...
While Ally Financial (ALLY) remains well poised for top-line improvement supported by retail loan growth and strong originations, mounting costs might hurt profits.